MMP9 and infection: ABZ-treated groups (Fig. 3c, d) and MTF-treated groups (Fig. 3e, f) exhibited decreased MMP-9 production at both time periods post-infection, with more pronounced effects seen during the acute phase rather than the chronic phase of the infection.